Australian biotech market today 18.03.09
Wednesday, 18 March, 2009
Pharma and biotech stocks were down slightly at 2.30pm today, on an up-and-down day for the All Ords.
Alchemia (ASX:ACL) is up yet again on the market today, trading at 32c and still basking in the washout from its partner filing a new drug application for generic fondaparinux.
Avexa (ASX:AVX) is down a touch from its recent gains, Biota (ASX:BTA) is up 5c to 61c and Cytopia (ASX:CYT) is up a cent.
Cochlear (ASX:COH) keeps rising and is now trading over $50 while CSL (ASX:CSL) is down a bit.
Newly listed Genera Biosystems (ASX:GBI) is active, up 2c, as is Halcygen (ASX:HGN).
Mesoblast (ASX:MSB) is down 2c, while Nanosonics (ASX:NAN) is up.
Universal Biosensors (ASX:UBI) is up 5c.
Beta blockers could halt triple negative breast cancer
Researchers have identified a molecular biomarker in triple negative breast cancer tumours which...
Common arthritis drug also lowers blood pressure
Scientists have known for a while that methotrexate helps with inflammation, but it may also help...
AI enables precise gene editing
A newly developed tool utilises AI to predict how cells repair their DNA after it is cut by gene...
